Gene-silencing study finds new targets for Parkinson’s disease

Sunday, November 24, 2013

NIH study sheds light on treatment of related disorders

Scientists at the National Institutes of Health have used RNA interference (RNAi) technology to reveal dozens of genes which may represent new therapeutic targets for treating Parkinson’s disease. The findings also may be relevant to several diseases caused by damage to mitochondria, the biological power plants found in cells throughout the body.